Advanced Search Results

50 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
EGFR and TNFRSF1A epidermal growth factor receptor TNF receptor superfamily member 1A
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • Signaling by EGFR
  • GRB2 events in EGFR signaling
  • GAB1 signalosome
  • SHC1 events in EGFR signaling
  • EGFR downregulation
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • EGFR interacts with phospholipase C-gamma
  • EGFR Transactivation by Gastrin
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Signal transduction by L1
  • Constitutive Signaling by EGFRvIII
  • Inhibition of Signaling by Overexpressed EGFR
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • PTK6 promotes HIF1A stabilization
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Extra-nuclear estrogen signaling
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • HCMV Early Events
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • TNF signaling
  • Cetuximab
  • Trastuzumab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Alvocidib
  • IGN311
  • Matuzumab
  • Vandetanib
  • Rindopepimut
  • Canertinib
  • Pelitinib
  • Varlitinib
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • Afatinib
  • Osimertinib
  • Necitumumab
  • Depatuxizumab mafodotin
  • Icotinib
  • Neratinib
  • Zalutumumab
  • Brigatinib
  • Olmutinib
  • 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One
  • Choriocarcinoma
  • Gastric cancer
  • Bladder cancer
  • Oral cancer
  • Glioma
  • Laryngeal cancer
  • Cervical cancer
  • Esophageal cancer
  • Tumor necrosis factor receptor-associated periodic syndrome (TRAPS); Familial periodic fever
TNF and TNFRSF1A tumor necrosis factor TNF receptor superfamily member 1A
  • Transcriptional regulation of white adipocyte differentiation
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • TNFR2 non-canonical NF-kB pathway
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • TNF signaling
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • TNF signaling
  • Etanercept
  • Adalimumab
  • Infliximab
  • Chloroquine
  • Epinephrine
  • Pseudoephedrine
  • Thalidomide
  • Glucosamine
  • Clenbuterol
  • Pranlukast
  • Amrinone
  • Isopropyl Alcohol
  • Afelimomab
  • YSIL6
  • SD118
  • PN0621
  • OMS-103HP
  • Talmapimod
  • VX-702
  • Apremilast
  • CRx-139
  • CYT007-TNFQb
  • Andrographolide
  • Ethyl pyruvate
  • AME-527
  • Dexanabinol
  • Golimumab
  • Certolizumab pegol
  • Pomalidomide
  • Binimetinib
  • Dilmapimod
  • 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One
  • Graft-versus-host disease
  • Asthma
  • Allograft rejection
  • Systemic lupus erythematosus
  • Tumor necrosis factor receptor-associated periodic syndrome (TRAPS); Familial periodic fever
TNF and TNFRSF1B tumor necrosis factor TNF receptor superfamily member 1B
  • Transcriptional regulation of white adipocyte differentiation
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • TNFR2 non-canonical NF-kB pathway
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • TNF signaling
  • TNFR2 non-canonical NF-kB pathway
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • Etanercept
  • Adalimumab
  • Infliximab
  • Chloroquine
  • Epinephrine
  • Pseudoephedrine
  • Thalidomide
  • Glucosamine
  • Clenbuterol
  • Pranlukast
  • Amrinone
  • Isopropyl Alcohol
  • Afelimomab
  • YSIL6
  • SD118
  • PN0621
  • OMS-103HP
  • Talmapimod
  • VX-702
  • Apremilast
  • CRx-139
  • CYT007-TNFQb
  • Andrographolide
  • Ethyl pyruvate
  • AME-527
  • Dexanabinol
  • Golimumab
  • Certolizumab pegol
  • Pomalidomide
  • Binimetinib
  • Dilmapimod
  • Etanercept
  • Graft-versus-host disease
  • Asthma
  • Allograft rejection
  • Systemic lupus erythematosus
  • Graft-versus-host disease
TGFB1 and TGFB2 transforming growth factor beta 1 transforming growth factor beta 2
  • Platelet degranulation
  • Influenza Virus Induced Apoptosis
  • Cell surface interactions at the vascular wall
  • Molecules associated with elastic fibres
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Syndecan interactions
  • ECM proteoglycans
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • Transcriptional regulation of white adipocyte differentiation
  • UCH proteinases
  • Interleukin-4 and Interleukin-13 signaling
  • RUNX3 regulates CDKN1A transcription
  • Regulation of RUNX3 expression and activity
  • RUNX3 regulates p14-ARF
  • Platelet degranulation
  • Molecules associated with elastic fibres
  • ECM proteoglycans
  • Hyaluronidase
  • Hyaluronidase (Human Recombinant)
  • Graft-versus-host disease
  • Allograft rejection
  • Camurati-Engelmann disease; Progressive diaphyseal dysplasia
  • Graft-versus-host disease
  • Allograft rejection
TGFB1 and LTBP4 transforming growth factor beta 1 latent transforming growth factor beta binding protein 4
  • Platelet degranulation
  • Influenza Virus Induced Apoptosis
  • Cell surface interactions at the vascular wall
  • Molecules associated with elastic fibres
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Syndecan interactions
  • ECM proteoglycans
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • Transcriptional regulation of white adipocyte differentiation
  • UCH proteinases
  • Interleukin-4 and Interleukin-13 signaling
  • RUNX3 regulates CDKN1A transcription
  • Regulation of RUNX3 expression and activity
  • RUNX3 regulates p14-ARF
  • Molecules associated with elastic fibres
  • Hyaluronidase
  • Hyaluronidase (Human Recombinant)
  • Graft-versus-host disease
  • Allograft rejection
  • Camurati-Engelmann disease; Progressive diaphyseal dysplasia
  • Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities; Urban-Rifkin-Davis syndrome
IKBKG and TNFRSF1A inhibitor of nuclear factor kappa B kinase regulatory subunit gamma TNF receptor superfamily member 1A
  • Activation of NF-kappaB in B cells
  • Activation of NF-kappaB in B cells
  • ER-Phagosome pathway
  • NOD1/2 Signaling Pathway
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIP-mediated NFkB activation via ZBP1
  • Downstream TCR signaling
  • FCERI mediated NF-kB activation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • activated TAK1 mediates p38 MAPK activation
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • SUMOylation of immune response proteins
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • IKBKB deficiency causes SCID
  • IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
  • IkBA variant leads to EDA-ID
  • CLEC7A (Dectin-1) signaling
  • MAP3K8 (TPL2)-dependent MAPK1/3 activation
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • IRAK1 recruits IKK complex
  • IKK complex recruitment mediated by RIP1
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • TNF signaling
  • AGRO100
  • Tarenflurbil
  • 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One
  • Ectodermal dysplasia associated immunodeficiency (EDA-ID), including the following two diseases: NF-kappa-B essential modulator (NEMO) defect; Inhibitor of kappa-B (I-kappa-B) defect
  • Incontinentia pigmenti
  • Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID); Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema
  • Tumor necrosis factor receptor-associated periodic syndrome (TRAPS); Familial periodic fever
NKX2-5 and HIPK2 NK2 homeobox 5 homeodomain interacting protein kinase 2
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Physiological factors
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • SUMOylation of transcription cofactors
  • Physiological factors
  • Regulation of TP53 Activity through Phosphorylation
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
  • Regulation of MECP2 expression and activity
  • Atrial septal defect
  • Tetralogy of Fallot
  • Congenital nongoitrous hypothyroidism (CHNG)
NOTCH1 and LCK notch receptor 1 LCK proto-oncogene, Src family tyrosine kinase
  • Pre-NOTCH Processing in the Endoplasmic Reticulum
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Processing in Golgi
  • Pre-NOTCH Processing in Golgi
  • Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
  • NOTCH1 Intracellular Domain Regulates Transcription
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
  • Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Notch-HLH transcription pathway
  • Defective LFNG causes SCDO3
  • RUNX3 regulates NOTCH signaling
  • RUNX3 regulates NOTCH signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH4 Intracellular Domain Regulates Transcription
  • GPVI-mediated activation cascade
  • PIP3 activates AKT signaling
  • Signaling by SCF-KIT
  • Signaling by SCF-KIT
  • Regulation of KIT signaling
  • Nef and signal transduction
  • Nef Mediated CD4 Down-regulation
  • Downstream TCR signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Translocation of ZAP-70 to Immunological synapse
  • Generation of second messenger molecules
  • PECAM1 interactions
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • DAP12 signaling
  • DAP12 signaling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • CD28 dependent Vav1 pathway
  • CTLA4 inhibitory signaling
  • PD-1 signaling
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Interleukin-2 signaling
  • Dasatinib
  • {4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid
  • Staurosporine
  • 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • (4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE
  • 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE
  • N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
  • N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
  • N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine
  • Ponatinib
  • Nintedanib
  • Bicuspid aortic valve
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
  • Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
PQBP1 and SFTPC polyglutamine binding protein 1 surfactant protein C
  • mRNA Splicing - Major Pathway
  • Surfactant metabolism
  • Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)
  • Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)
  • Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
  • Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
  • Non-syndromic X-linked mental retardation
  • Pulmonary surfactant metabolism dysfunction (SMDP)
STAT1 and TNFRSF1A signal transducer and activator of transcription 1 TNF receptor superfamily member 1A
  • Interleukin-6 signaling
  • ISG15 antiviral mechanism
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-20 family signaling
  • Regulation of RUNX2 expression and activity
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Growth hormone receptor signaling
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • TNF signaling
  • 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One
  • Chronic Mucocutaneous Candidiasis (CMC); Familial candidiasis (CANDF)
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
  • Tumor necrosis factor receptor-associated periodic syndrome (TRAPS); Familial periodic fever
STAT1 and TNFRSF1B signal transducer and activator of transcription 1 TNF receptor superfamily member 1B
  • Interleukin-6 signaling
  • ISG15 antiviral mechanism
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-20 family signaling
  • Regulation of RUNX2 expression and activity
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Growth hormone receptor signaling
  • TNFR2 non-canonical NF-kB pathway
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • Etanercept
  • Chronic Mucocutaneous Candidiasis (CMC); Familial candidiasis (CANDF)
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
  • Graft-versus-host disease
STAT1 and CSF2RB signal transducer and activator of transcription 1 colony stimulating factor 2 receptor subunit beta
  • Interleukin-6 signaling
  • ISG15 antiviral mechanism
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-20 family signaling
  • Regulation of RUNX2 expression and activity
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Growth hormone receptor signaling
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • RAF/MAP kinase cascade
  • Surfactant metabolism
  • Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)
  • Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
  • Interleukin receptor SHC signaling
  • Sargramostim
  • NPI 32101
  • Resatorvid
  • Chronic Mucocutaneous Candidiasis (CMC); Familial candidiasis (CANDF)
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
NOTCH1 and ITCH notch receptor 1 itchy E3 ubiquitin protein ligase
  • Pre-NOTCH Processing in the Endoplasmic Reticulum
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Processing in Golgi
  • Pre-NOTCH Processing in Golgi
  • Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
  • NOTCH1 Intracellular Domain Regulates Transcription
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
  • Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Notch-HLH transcription pathway
  • Defective LFNG causes SCDO3
  • RUNX3 regulates NOTCH signaling
  • RUNX3 regulates NOTCH signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH4 Intracellular Domain Regulates Transcription
  • Downregulation of ERBB4 signaling
  • NOD1/2 Signaling Pathway
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Degradation of GLI1 by the proteasome
  • Hedgehog 'on' state
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Negative regulators of DDX58/IFIH1 signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Bicuspid aortic valve
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
NOTCH1 and RELA notch receptor 1 RELA proto-oncogene, NF-kB subunit
  • Pre-NOTCH Processing in the Endoplasmic Reticulum
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Processing in Golgi
  • Pre-NOTCH Processing in Golgi
  • Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
  • NOTCH1 Intracellular Domain Regulates Transcription
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
  • Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Notch-HLH transcription pathway
  • Defective LFNG causes SCDO3
  • RUNX3 regulates NOTCH signaling
  • RUNX3 regulates NOTCH signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH4 Intracellular Domain Regulates Transcription
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Regulated proteolysis of p75NTR
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated NF-kB activation
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • PKMTs methylate histone lysines
  • Transcriptional regulation of white adipocyte differentiation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Interleukin-1 processing
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • CD209 (DC-SIGN) signaling
  • CLEC7A/inflammasome pathway
  • The NLRP3 inflammasome
  • Transcriptional Regulation by VENTX
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • Purinergic signaling in leishmaniasis infection
  • Dimethyl fumarate
  • Bicuspid aortic valve
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
APOB and LRP2 apolipoprotein B LDL receptor related protein 2
  • Cell surface interactions at the vascular wall
  • Scavenging by Class B Receptors
  • Scavenging by Class B Receptors
  • Scavenging by Class A Receptors
  • Scavenging by Class A Receptors
  • Scavenging by Class F Receptors
  • Scavenging by Class F Receptors
  • Scavenging by Class H Receptors
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Platelet sensitization by LDL
  • Regulation of TLR by endogenous ligand
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • VLDL assembly
  • Post-translational protein phosphorylation
  • Chylomicron assembly
  • Chylomicron remodeling
  • Chylomicron clearance
  • Chylomicron clearance
  • LDL clearance
  • LDL clearance
  • LDL remodeling
  • VLDL clearance
  • VLDL clearance
  • Retinoid metabolism and transport
  • Retinoid metabolism and transport
  • Vitamin D (calciferol) metabolism
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Retinoid metabolism and transport
  • Urokinase
  • Insulin Human
  • Insulin Pork
  • Gentamicin
  • Hypercholesterolemia, autosomal dominant; Hyperlipoproteinemia, type IIa
  • Donnai-Barrow syndrome; Faciooculoacousticorenal syndrome
BMP4 and HTRA1 bone morphogenetic protein 4 HtrA serine peptidase 1
  • Molecules associated with elastic fibres
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • Degradation of the extracellular matrix
  • Calcium
  • Anophthalmia and microphthalmia (A/M)
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
CAV1 and TNFRSF1B caveolin 1 TNF receptor superfamily member 1B
  • Triglyceride catabolism
  • eNOS activation
  • NOSTRIN mediated eNOS trafficking
  • Basigin interactions
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • VEGFR2 mediated vascular permeability
  • Extra-nuclear estrogen signaling
  • FOXO-mediated transcription of cell cycle genes
  • TNFR2 non-canonical NF-kB pathway
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • Etanercept
  • Congenital generalized lipodystrophy (CGL)
  • Graft-versus-host disease
CHUK and TNFRSF1A component of inhibitor of nuclear factor kappa B kinase complex TNF receptor superfamily member 1A
  • Activation of NF-kappaB in B cells
  • Activation of NF-kappaB in B cells
  • ER-Phagosome pathway
  • NOD1/2 Signaling Pathway
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIP-mediated NFkB activation via ZBP1
  • AKT phosphorylates targets in the cytosol
  • Downstream TCR signaling
  • FCERI mediated NF-kB activation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • IKBKB deficiency causes SCID
  • IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
  • IkBA variant leads to EDA-ID
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • Constitutive Signaling by AKT1 E17K in Cancer
  • NIK - noncanonical NF-kB signaling
  • MAP3K8 (TPL2)-dependent MAPK1/3 activation
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • IRAK1 recruits IKK complex
  • IKK complex recruitment mediated by RIP1
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • TNFs bind their physiological receptors
  • Interleukin-10 signaling
  • TNF signaling
  • Aminosalicylic Acid
  • Mesalazine
  • Sulfasalazine
  • Acetylcysteine
  • 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One
  • Cocoon syndrome
  • Tumor necrosis factor receptor-associated periodic syndrome (TRAPS); Familial periodic fever
ROBO2 and BNIP3L roundabout guidance receptor 2 BCL2 interacting protein 3 like
  • Signaling by ROBO receptors
  • Signaling by ROBO receptors
  • Regulation of commissural axon pathfinding by SLIT and ROBO
  • Regulation of cortical dendrite branching
  • Regulation of expression of SLITs and ROBOs
  • ROBO receptors bind AKAP5
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • Vesicoureteral reflux
CAV1 and NOS3 caveolin 1 nitric oxide synthase 3
  • Triglyceride catabolism
  • eNOS activation
  • NOSTRIN mediated eNOS trafficking
  • Basigin interactions
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • VEGFR2 mediated vascular permeability
  • Extra-nuclear estrogen signaling
  • FOXO-mediated transcription of cell cycle genes
  • ROS and RNS production in phagocytes
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • eNOS activation
  • NOSTRIN mediated eNOS trafficking
  • NOSIP mediated eNOS trafficking
  • Nitric oxide stimulates guanylate cyclase
  • VEGFR2 mediated vascular permeability
  • Extra-nuclear estrogen signaling
  • L-Arginine
  • L-Citrulline
  • Sapropterin
  • Miconazole
  • N,N-dimethylarginine
  • L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide
  • L-2-Amino-4-(Guanidinooxy)Butyric Acid
  • 3-Bromo-7-Nitroindazole
  • N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine
  • N-(3-(Aminomethyl)Benzyl)Acetamidine
  • 1,2,4-Triazole-Carboxamidine
  • L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide
  • S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea
  • 7-Nitroindazole
  • S-Ethylisothiourea
  • 2-Aminothiazoline
  • Se-Ethyl-Isoselenourea
  • 2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine
  • N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane
  • Cacodylic acid
  • 7-Nitroindazole-2-Carboxamidine
  • 6-Nitroindazole
  • N-Omega-Hydroxy-L-Arginine
  • N5-Iminoethyl-L-Ornithine
  • 5,6-Cyclic-Tetrahydropteridine
  • S-Ethyl-N-Phenyl-Isothiourea
  • S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea
  • 6S-5,6,7,8-Tetrahydrobiopterin
  • S-(Dimethylarsenic)Cysteine
  • L-Homoarginine
  • S-Isopropyl-Isothiourea
  • Nitroarginine
  • 5-Nitroindazole
  • N-(Chlorophenyl)-N'-Hydroxyguanidine
  • Apremilast
  • (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine
  • 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE
  • ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
  • N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE
  • N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine
  • Congenital generalized lipodystrophy (CGL)
Page 1 out of 3 pages